The likely pathogenic CHEK2 c.319+2T>A variant identified in this study has previously been identified in another Norwegian patient diagnosed with thyroid cancer at age 31, BC at 43 and 48. The gene discussed is CHEK2; the disease is thyroid gland carcinoma.